158 results on '"Hidalgo, Luis G."'
Search Results
2. Novel Tools for the Study of HLA Class II Cross-isotype Pairings
3. Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes
4. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
5. Third-party vessel allografts in kidney and pancreas transplantation: Utilization, de novo DSAs, and outcomes
6. Natural Killer Cell Presence in Antibody-Mediated Rejection.
7. The Banff 2022 Kidney Meeting Report: Re-Appraisal of Microvascular Inflammation and the Role of Biopsy-Based Transcript Diagnostics
8. Review: The transcripts associated with organ allograft rejection
9. Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
10. Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
11. Immunology of simultaneous liver and kidney transplants with identification and prevention of rejection
12. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection—Results of a Cross-Sectional Screening Study
13. Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue
14. Modest Improvements in Refractory Antibody-Mediated Rejection After Prolonged Treatment
15. Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
16. NK cells in antibody‐mediated rejection – Key effector cells in microvascular graft damage
17. Missing Self and DSA—Synergy of Two NK Cell Activation Pathways in Kidney Transplantation
18. Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Injury in Kidney Transplant Recipients During the Time of the Coronavirus Disease 2019 Pandemic
19. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies
20. Short-Term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection
21. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant
22. An in vitro model of antibody-mediated injury to glomerular endothelial cells: Upregulation of MHC class II and adhesion molecules
23. Poster Board #-Session: P60-I Transcripts That Differentiate T Cell-Mediated from Antibody-Mediated Rejection Are Differentially Regulated in Human Macrophages.: Abstract# 717
24. Molecular diagnosis of ABMRwith or without donor‐specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes
25. Minimal data reporting standards for serological testing for histocompatibility
26. IFN-γ Decreases CTL Generation by Limiting IL-2 Production: A Feedback Loop Controlling Effector Cell Production
27. The role of B cells and alloantibody in the host response to human organ allografts
28. Heterogeneity in the Evolution and Mechanisms of the Lesions of Kidney Allograft Rejection in Mice
29. CYCLOSPORINE EXERTS NO STRONG TGF-β1 RELEASE IN MICE SPLENOCYTES
30. NK cells in antibody‐mediated rejection – Key effector cells in microvascular graft damage.
31. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection
32. Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis
33. Single-antigen Bead Assays to Define Unacceptable Antigen Mismatches?
34. A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
35. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment
36. OR4 Development of an in vitro model of human antibody mediated rejection
37. Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection
38. P060 Antibody-mediated and cellular rejection: How can they seem so similar?
39. DQB1 Mismatch in Living Donor Kidney Transplantation
40. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients
41. P014
42. Molecular Microscope Strategy to Improve Risk Stratification in Early Antibody-Mediated Kidney Allograft Rejection
43. Antibody-mediated rejection, T cell–mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies
44. An Analysis of Regulatory T-Cell and Th-17 Cell Dynamics during Cytomegalovirus Replication in Solid Organ Transplant Recipients
45. 43-OR
46. 25-P
47. 35-P Effects of cryopreservation and pronase treatment on HLA class I and II surface expression
48. 55-OR: NK cell transcript expression indicates the degree of microvascular disease activity in late antibody mediated rejection
49. 66-OR: MHC Class Ib Products Are Required to Prevent Early Collapse of the Microcirculation and Necrosis of Mouse Kidney Allografts
50. 44-OR: Microarray Analysis of Renal Transplant Biopsies Identify Transcripts Selectively Associated With DSA and Find NK Cells in Peritubular Capillaries in Biopsies Diagnosed as Antibody Mediated Rejection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.